Ranibizumab or bevacizumab in AMD?

首页> 外文期刊>Prescrire international >Ranibizumab or bevacizumab in AMD?

【24h】

Ranibizumab or bevacizumab in AMD?

机译：在AMD中的Ranibizumab或Bevacizumab？

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The Italian independent drug bulletin Informazioni sui Farmaci, a member of the International Society of Drug Bulletins (ISDB), published a review comparing ranibizumab versus bevacizumab ror age-related macular degeneration (AMD). Its conclusion differs from that of Prescrire's review, published in issue 163. Giulio Formoso and Maria Font have offered on behalf of Informazioni sui Farmaci to present their evaluations. The position of Informazioni sui Farmaci is recapped below, and an English translation of the full article published in the Italian bulletin is available at english.prescrire.org. Giulio Formoso and Maria Font's letter is followed by a few points outlining Prescrire's position, already set out in detail in issue 163.

机译：意大利独立药物公告Informazioni Sui Farmaci是国际药物公报（ISDB）的一名成员，发表了比较Ranibizumab与Bevacizumab ROR年龄相关的黄斑变性（AMD）的评论。其结论与预先征收的审查不同，发表于第163期。Giulio Formoso和Maria Font代表Informazioni Sui Farmaci提供了评估。 Informazioni Sui Farmaci的位置在下面重新签名，意大利公告中发表的完整文章的英文翻译是英文.prescrire.org提供的。 Giulio FormoSo和Maria字体的信件是概述了预定概要的几点，已经在第163条中详细列出。

著录项

来源
《Prescrire international》 |2016年第171期|共2页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词

相似文献

外文文献
中文文献
专利

1. Reactive Oxygen Species (ROS) Production in ARPE-19 Cybrids Containing Mitochondria From AMD Versus Age-matched Non-AMD Controls Treated with Aflibercept, Ranibizumab and Bevacizumab [J] . Costa Rodrigo, Caceres-del-Carpio Lavier, Thaker Kunal, Investigative ophthalmology & visual science . 2016,第12期

机译：ARPE-19含有线粒体的ARPE-19糖糖的活性氧物种（ROS）产生与AMD，AGES匹配的非AMD对照用AFLIBERCEPT，Ranibizumab和Bevacizumab进行治疗
2. Topical treatment for AMD: Non-invasive delivery and efficacy of ranibizumab and bevacizumab in rabbit and porcine eyes [J] . De Cogan Felicity, Lynch Aisling, Berwick Matthew, Investigative ophthalmology & visual science . 2018,第9期

机译：AMD的局部治疗：Ranibizumab和兔猪和猪眼中的无侵袭性递送和疗效
3. Topical treatment for AMD: Non-invasive delivery and efficacy of ranibizumab and bevacizumab in rabbit and porcine eyes [J] . De Cogan Felicity, Lynch Aisling, Berwick Matthew, Investigative ophthalmology & visual science . 2018,第9期

机译：AMD的局部治疗：Ranibizumab和兔猪和猪眼中的无侵袭性递送和疗效
4. Ready-to-Use Potency Assays for Bevacizumab, Aflibercept, and Ranibizumab [C] . Alpana Prasad, Paula Urqhart, Hanako Daino-Laizure, Protein Engineering Summit. . 2018

机译：Bevacizumab，AfliBelcept和Ranibizumab的即用效力效力测定
5. Characterizing response patterns to ranibizumab therapy in patients with wet age-related macular degeneration: A latent class growth analysis [D] . Sun, Diana 2015

机译：潮湿年龄相关性黄斑变性患者的ranibizumab治疗的表征反应模式：潜在的增长分析
6. Comparative Safety of Bevacizumab Ranibizumab and Aflibercept for Treatment of Neovascular Age-Related Macular Degeneration (AMD): A Systematic Review and Network Meta-Analysis of Direct Comparative Studies [O] . Anna A. Plyukhova, Maria V. Budzinskaya, Kirill M. Starostin, 2020

机译：贝伐单抗雷珠单抗和阿柏西普治疗新血管性年龄相关性黄斑变性（AMD）的比较安全性：直接比较研究的系统评价和网络Meta分析
7. Comparative Safety of Bevacizumab, Ranibizumab, and Aflibercept for Treatment of Neovascular Age-Related Macular Degeneration (AMD): A Systematic Review and Network Meta-Analysis of Direct Comparative Studies [O] . Anna A. Plyukhova, Maria V. Budzinskaya, Kirill M. Starostin, 2020

机译：Bevacizumab，Ranibizumab和AfliBercept的对比安全性治疗新生血管年龄相关性黄斑变性（AMD）：直接比较研究的系统审查和网络荟萃分析

Ranibizumab or bevacizumab in AMD?

摘要

著录项

相似文献

相关主题

期刊订阅